Heart failure and inflammation study for hospitalized patients
Part of Heart & circulation clinical trials.
This study looks at blood markers and body composition in people hospitalized for heart failure with preserved or mildly reduced heart function. It aims to understand inflammation and fluid status better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are hospitalized for worsening heart failure.
- Your heart's pumping ability is 40% or higher.
- You have signs of structural heart changes, like an enlarged left atrium or thickened heart walls.
- You do not have severe kidney disease (on dialysis or very low kidney function).
- You do not have an active infection, cancer (except minor skin cancer), or other serious conditions that may affect the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking for people who have had a heart attack or have heart failure to discover new markers in your blood that could help doctors better understand and treat heart disease. By collecting samples and health data, researchers hope to find clues that improve care for future patients.
This study looks for markers in the blood that can predict whether the heart's pumping function improves in people with chronic heart failure. It may help doctors understand which treatments work best for each person.
This study is looking at patients hospitalized with an acute cardiovascular condition to better understand inflammation. The goal is to create a registry that may help improve care for future patients.
This study looks at blood “markers” (substances in the blood) to help explain how some people move from early heart strain to full heart failure. You may be enrolled if you have stable or worsening heart failure symptoms, or you may qualify as a healthy control for comparison.
This study looks at certain proteins in your blood to help doctors better understand and diagnose a type of heart failure called HFpEF. You might be able to join if your doctor recently ordered a blood test for NT-proBNP because they thought you might have heart failure.
This study is looking for people with heart failure to help find better ways to measure fluid buildup (congestion). It involves extra blood tests or a short procedure called a right heart catheterization. The goal is to improve how doctors manage heart failure.
Hear when a new Inflammation Biomarkers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.